2-p-Fluoroanilino-3-(4-methoxycyclohexylimino)-5-(6-methoxy-3-pyridinyl)-3,5-dihydrophenazine

ID: ALA5172591

Chembl Id: CHEMBL5172591

PubChem CID: 168271160

Max Phase: Preclinical

Molecular Formula: C31H30FN5O2

Molecular Weight: 523.61

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-n2c3c/c(=N\C4CCC(OC)CC4)c(Nc4ccc(F)cc4)cc-3nc3ccccc32)cn1

Standard InChI:  InChI=1S/C31H30FN5O2/c1-38-24-14-11-22(12-15-24)35-27-18-30-28(17-26(27)34-21-9-7-20(32)8-10-21)36-25-5-3-4-6-29(25)37(30)23-13-16-31(39-2)33-19-23/h3-10,13,16-19,22,24,34H,11-12,14-15H2,1-2H3/b35-27+

Standard InChI Key:  RDOLTSJROSPIKO-ROMHNNFLSA-N

Alternative Forms

  1. Parent:

    ALA5172591

    ---

Associated Targets(Human)

Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lyssavirus rabies (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 523.61Molecular Weight (Monoisotopic): 523.2384AlogP: 6.27#Rotatable Bonds: 6
Polar Surface Area: 73.56Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 6.49CX LogP: 5.74CX LogD: 5.69
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.27Np Likeness Score: -1.08

References

1. Zhang X, Shi Y, Guo Z, Zhao X, Wu J, Cao S, Liu Y, Li Y, Huang W, Wang Y, Liu Q, Li Y, Song D..  (2022)  Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism.,  234  [PMID:35279610] [10.1016/j.ejmech.2022.114209]

Source